$NKTX
Nkarta, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$2.27
▼-1.76%-$0.041
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateNkarta, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Flagged at $2.87 at 09:08 AM on Sep 08, then ran to $3.30 +15% that session.
The high is the session peak after our first alert, not a realized trade. Not investment advice.
Why is NKTX down today? It is at $2.27 (-1.76%), and our scanner flagged it 52 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment NKTX spikes, and full due diligence on NKTX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $NKTX 52 times in the last 30 days. Create a free account to track $NKTX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
NKTX is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 2 unusual-volume and momentum alerts on NKTX today, peaking at 5.1x its normal volume.
Likely catalystNkarta, Inc.: Q2 FY2026 results, three months to Jun 30, 2026, from the latest SEC filing. Read it →A share sale has already completed, so that supply is out there. Size not stated in the filing.
Some filings did not state a size, so these are floors.
Recent share offering + active shelf on file — the company raised capital and can raise more
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Hastings Paul J Officer | Sold (automatic/other) | -2K | sold 0.5% | 390K | $5K at $2.71 | Jun 18, 26 |
Mahmood Nadir Officer | Sold (automatic/other) | -6K | sold 3.3% | 168K | $12K at $2.07 | Jan 15, 26 |
Hastings Paul J Officer | Sold (automatic/other) | -26K 0.04% of company | sold 6.3% | 390K | $54K at $2.07 | Jan 15, 26 |
Hastings Paul J Officer | Acquired (grant/award) | +94K 0.1% of company | added 29% | 416K | n/a | Jan 6, 26 |
Mahmood Nadir Officer | Acquired (grant/award) | +80K 0.1% of company | added 86% | 173K | n/a | Jan 6, 26 |
Rose Shawn Marshall Officer | Acquired (grant/award) | +70K 0.10% of company | n/a | 70K | n/a | Jan 6, 26 |
Hastings Paul J Officer | Sold (automatic/other) | -2K | sold 0.6% | 320K | $3K at $1.79 | Jun 18, 25 |
Hager Alicia J. Officer | Sold (automatic/other) | -10K 0.01% of company | sold 6.1% | 147K | $21K at $2.20 | Jan 15, 25 |
Hastings Paul J Officer | Sold (automatic/other) | -17K 0.02% of company | sold 5.2% | 320K | $38K at $2.20 | Jan 15, 25 |
Brandenberger Ralph Officer | Sold (automatic/other) | -7K 0.01% of company | sold 5.6% | 125K | $16K at $2.20 | Jan 15, 25 |
Levin Alyssa Officer | Sold (automatic/other) | -6K | sold 5.4% | 103K | $13K at $2.20 | Jan 15, 25 |
Shook David Officer | Sold (automatic/other) | -9K 0.01% of company | sold 4.3% | 191K | $19K at $2.20 | Jan 15, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
NKTX is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 2 unusual-volume and momentum alerts on NKTX today, peaking at 5.1x its normal volume.
NKTX last traded at $2.27, down 1.76% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Nkarta, Inc. Common Stock (NKTX) is next expected to report earnings on Monday, November 9, 2026, about 33 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The NKTX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged NKTX 52 times in the last 30 days.
NKTX (Nkarta, Inc. Common Stock) trades on XNAS, with a market cap of about $165M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge NKTX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$NKTX discussion
Sign in to ask a question or join the discussion.